Molecular, pharmacological and functional diversity of 5-HT receptors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adham, 1998, Functional characterization of the recombinant human 5-hydroxytryptamine 7(a) receptor isoform coupled to adenylate cyclase stimulation, J Pharmacol Exp Ther, 287, 508
Aghajanian, 1995, Electrophysiology of serotonin receptor subtypes and signal tranduction pathways, 1451
Aghajanian, 1999, Serotonin and hallucinogens, Neuropsychopharmacology, 21, 16S, 10.1038/sj.npp.1395318
Artigas, 2001, How does pindolol improve antidepressant action?, Trends Pharmacol Sci, 22, 224, 10.1016/S0165-6147(00)01682-5
Ase, 2001, Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout, J Neurochem, 78, 619, 10.1046/j.1471-4159.2001.00437.x
Baker, 1998, Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor, J Biol Chem, 273, 17469, 10.1074/jbc.273.28.17469
Bard, 1993, Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase, J Biol Chem, 268, 23422, 10.1016/S0021-9258(19)49479-9
Barnes, 1998, Neurochemical consequences following pharmacological manipulation of central 5-HT4 receptors, 103
Barone, 1993, Quantitative autoradiography of 5-HT1E binding sites in rodent brains: effect of lesion of serotonergic neurons, Eur J Pharmacol, 249, 221, 10.1016/0014-2999(93)90436-L
Barone, 1994, Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain, Brain Res, 638, 85, 10.1016/0006-8993(94)90636-X
Beer, 1993, L 694247: a potent 5-HT1D receptor agonist, Br J Pharmacol, 110, 1196, 10.1111/j.1476-5381.1993.tb13941.x
Bender, 2000, Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant, J Neurochem, 74, 478, 10.1046/j.1471-4159.2000.740478.x
Bennett, 1976, Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors, Mol Pharmacol, 12, 373
Bentue-Ferrer, 1998, 5-HT-moduline, a 5-HT1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis, Eur J Pharmacol, 358, 129, 10.1016/S0014-2999(98)00586-X
Bervoets, 1993, 5-HT1A receptors and the tail-flick response. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurons mediate spontaneous tail-flicks in the rat, J Pharmacol Exp Ther, 264, 95
Bickerdike, 1999, 5-HT2C receptor modulation and the treatment of obesity, Diabetes, Obes Metab, 1, 207, 10.1046/j.1463-1326.1999.00037.x
Bill, 1991, Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia, Br J Pharmacol, 103, 1857, 10.1111/j.1476-5381.1991.tb12342.x
Blondel, 1997, Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium, FEBS Lett, 412, 465, 10.1016/S0014-5793(97)00820-X
Blondel, 1998, Cloning, expression and pharmacology of four human 5-hydroxy tryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus, J Neurochem, 70, 2252, 10.1046/j.1471-4159.1998.70062252.x
Bockaert, 1992, The 5-HT4 receptor: a place in the sun, Trends Pharmacol Sci, 13, 141, 10.1016/0165-6147(92)90051-7
Boess, 1994, Molecular biology of 5-HT receptors, Neuropharmacology, 33, 275, 10.1016/0028-3908(94)90059-0
Boess, 1995, Ultrastructure of the 5-hydroxytryptamine 3 receptor, J Neurochem, 64, 1401, 10.1046/j.1471-4159.1995.64031401.x
Boger, 2000, Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide, Proc Natl Acad Sci U S A, 97, 5044, 10.1073/pnas.97.10.5044
Bonhaus, 1994, [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain, J Pharmacol Exp Ther, 271, 484
Bonhaus, 1997, RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist, Neuropharmacology, 36, 621, 10.1016/S0028-3908(97)00049-X
Bonhaus, 1999, RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist, Br J Pharmacol, 127, 1075, 10.1038/sj.bjp.0702632
Bonnin, 1999, Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas, Brain Res, 825, 152, 10.1016/S0006-8993(99)01265-2
Bos, 2001, 5-HT6 receptor antagonists: lead-optimization and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides, Eur J Med Chem, 36, 165, 10.1016/S0223-5234(00)01209-5
Bourin, 2001, Drug mechanisms in anxiety, Curr Opin Invest Drugs, 2, 259
Bourson, 1995, Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides, J Pharmacol Exp Ther, 274, 173
Boyd, 1994, Urinary disorders associated with cisapride. Adverse Drug Reactions Advisory Committee, Med J Aust, 160, 579, 10.5694/j.1326-5377.1994.tb138353.x
Bradley, 1986, Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine, Neuropharmacology, 25, 563, 10.1016/0028-3908(86)90207-8
Branchek, 1997, Molecular biology and potential functional role of 5-HT5, 5-HT6, and 5-HT7 receptors, Handb Exp Pharmacol, 129, 475, 10.1007/978-3-642-60921-3_18
Branchek, 2000, 5-ht6 receptors as emerging targets for drug discovery, Annu Rev Pharmacol Toxicol, 40, 319, 10.1146/annurev.pharmtox.40.1.319
Bromidge, 1999, 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT6 Receptor Antagonist, Med Chem, 42, 202, 10.1021/jm980532e
Bromidge, 2001, Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134), Bioorg Med Chem Lett, 11, 55, 10.1016/S0960-894X(00)00597-7
Bruinvels, 1991, Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand, Eur J Pharmacol, 202, 89, 10.1016/0014-2999(91)90257-Q
Bruinvels, 1994, Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor mRNA in rodent and primate brain, Neuropharmacology, 33, 367, 10.1016/0028-3908(94)90067-1
Buchheit, 1986, The rat isolated stomach fundus strip, a model for 5-HT1C receptors, Br J Pharmacol, 88, 367P
Buchheit, 1995, The serotonin 5-HT4 receptor: Part 2. Structure activity studies of the indolecarbazimidamide agonist, J Med Chem, 38, 2331, 10.1021/jm00013a010
Buhlen, 1996, Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex, Naunyn-Schmiedeberg's Arch Pharmacol, 353, 281, 10.1007/BF00168629
Burns, 1997, Regulation of serotonin-2C receptor G-protein coupling by RNA editing, Nature, 387, 303, 10.1038/387303a0
Carson, 1996, The 5-HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes, Glia, 17, 317, 10.1002/(SICI)1098-1136(199608)17:4<317::AID-GLIA6>3.0.CO;2-W
Carter, 1995, Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum, Eur J Pharmacol, 280, 243, 10.1016/0014-2999(95)00195-Q
Castro, 1997, Identification and characterisation of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain, J Neurochem, 69, 2123, 10.1046/j.1471-4159.1997.69052123.x
Cheetham, 1993, Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor, Br J Pharmacol, 110, 1621, 10.1111/j.1476-5381.1993.tb14010.x
Claeysen, 1997, Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase, NeuroReport, 8, 3189, 10.1097/00001756-199710200-00002
Claeysen, 1999, Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain, Mol Pharmacol, 55, 910
Clark, 1998, Medicinal chemistry of 5-HT4 receptor ligands, 1
Clarke, 1989, The 5-HT4 receptor: naughty but nice, Trends Pharmacol Sci, 10, 385, 10.1016/0165-6147(89)90177-6
Clemett, 1999, Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors, Br J Pharmacol, 127, 236, 10.1038/sj.bjp.0702503
Clineschmidt, 1985, Characterisation of 5-Hydroxytryptamine receptors in rat stomach fundus, J Pharmacol Exp Ther, 243, 264
Cloez-Tayarani, 1997, Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors, Proc Nat Acad Sci U S A, 94, 9899, 10.1073/pnas.94.18.9899
Cloez-Tayarani, 1998, Mapping of 5-HT-moduline binding sites in guinea-pig brain by film and digital autoradiography, Brain Res, 798, 311, 10.1016/S0006-8993(98)00393-X
Cohen, 1986, Further evidence that the serotonin receptor in the rat stomach fundus is not 5-HT1A or 5-HT1B, Life Sci, 38, 1, 10.1016/0024-3205(86)90267-5
Conner, 1990, Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB 20: a novel 5-hydroxytryptamine receptor, Mol Pharmacol, 37, 742
Cox, 1996, 5-HT2B receptor signaling in the rat stomach fundus: dependence on calcium influx, calcium release and protein kinase C, Behav Brain Res, 73, 289, 10.1016/0166-4328(96)00125-8
Crabbe, 1996, Elevated alcohol consumption in null mutant mice lacking 5-HT1B, Nat Genet, 14, 98, 10.1038/ng0996-98
Crabbe, 1999, Genetics of mouse behaviour: interactions with laboratory environment, Science, 284, 670, 10.1126/science.284.5420.1670
Cutrer, 1999, Effects of PNU 109291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis, Neuropharmacology, 38, 1043, 10.1016/S0028-3908(99)00032-5
Davies, 1999, The 5-HT3B subunit is a major determinant of serotonin-receptor function, Nature, 397, 359, 10.1038/16941
Day, 1963, An analysis of the direct and indirect actions of drugs on the isolated guinea pig ileum, Br J Pharmacol, 20, 150
De Koning, 1994, Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study, Int Clin Psychopharmacol, 9, 187, 10.1097/00004850-199409000-00007
De Ponti, 2001, Irritable bowel syndrome: new agents targeting serotonin receptor subtypes, Drugs, 61, 317, 10.2165/00003495-200161030-00001
Dekeyne, 1999, Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist Ro 60-0175: a pharmacological analysis, Neuropharmacology, 38, 415, 10.1016/S0028-3908(98)00203-2
Den Boer, 2000, Serotonergic drugs in the treatment of depressive and anxiety disorders, Hum Psychopharmacol, 15, 315, 10.1002/1099-1077(200007)15:5<315::AID-HUP204>3.0.CO;2-Y
Domenech, 1997, Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabeled serotonin 5HT1D/1B receptor antagonist, Naunyn-Schmiedeberg's Arch Pharmacol, 356, 328, 10.1007/PL00005058
Dreteler, 1991, Systemic and regional Haemodynamic effects of the 5-hydroxytryptamine 1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat, J Cardiovasc Pharmacol, 17, 488, 10.1097/00005344-199103000-00019
Dubin, 1999, The pharmacological and functional characteristics of the serotonin 5-HT3A receptor are specifically modified by a 5-HT3B receptor subunit, J Biol Chem, 274, 30799, 10.1074/jbc.274.43.30799
Dubin, 2001, Protein and cDNA sequences of a human subunit 5-HT3C of the 5-HT3 serotonin receptor and uses thereof, PCT Int Appl, 80
Duxon, 1997, Evidence for expression of the 5-hydroxytryptamine 2B receptor protein in the rat central nervous system, Neuroscience (Oxford), 76, 323, 10.1016/S0306-4522(96)00480-0
Duxon, 1997, Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat, Neuropharmacology, 36, 601, 10.1016/S0028-3908(97)00042-7
Eglen, 1997, 5-Hydroxytryptamine (5-HT)4 receptors and central nervous system function: an update, Prog Drug Res, 49, 9
Erlander, 1993, Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain, Proc Natl Acad Sci U S A, 90, 3452, 10.1073/pnas.90.8.3452
Errico, 2001, 5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons, Neuroscience (Oxford), 102, 361, 10.1016/S0306-4522(00)00460-7
Fargin, 1988, The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor, Nature, 335, 358, 10.1038/335358a0
Feniuk, 1983, 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle, Eur J Pharmacol, 96, 71, 10.1016/0014-2999(83)90530-7
Fillion, 2000, Potential of 5-HT-moduline as a drug target for affective disorders, Curr Opin Invest Drugs, 1, 104
Fillion, 1996, A new peptide, 5-HT-moduline, isolated and purified from mammalian brain specifically interacts with 5-HT1B/1D receptors, Behav Brain Res, 73, 313, 10.1016/0166-4328(96)00120-9
Fiorella, 1995, The interactions of typical and atypical antipsychotics with the (−)2,5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus, Neuropharmacology, 34, 1297, 10.1016/0028-3908(95)00101-B
Fiorella, 1995, Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs: II. Reassessment of LSD false positives, Psychopharmacology, 121, 357, 10.1007/BF02246075
Fitzgerald, 1999, Messenger RNA editing of the human serotonin 5-HT2C receptor, Neuropsychopharmacology, 21, 82S, 10.1038/sj.npp.1395328
Fitzgerald, 2000, Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine, Mol Pharmacol, 57, 75
Fletcher, 1996, Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist, Behav Brain Res, 73, 337, 10.1016/0166-4328(96)00118-0
Fone, 1989, Involvement of 5-HT2 receptors in the behaviors produced by intrathecal administration of selected 5-HT agonists and the TRH analog (CG 3509) to rats, Br J Pharmacol, 96, 599, 10.1111/j.1476-5381.1989.tb11858.x
Forster, 1995, A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY 100635, Eur J Pharmacol, 281, 81, 10.1016/0014-2999(95)00234-C
Francken, 1998, The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK-293 cells, Eur J Pharmacol, 361, 299, 10.1016/S0014-2999(98)00744-4
Francken, 2000, Human 5-hydroxytryptamine 5A receptors activate coexpressed Gi and Go proteins in Spodoptera frugiperda-9 cells, Mol Pharmacol, 57, 1034
Gaddum, 1957, Two kinds of tryptamine receptor, Br J Pharmacol Chemother, 12, 323, 10.1111/j.1476-5381.1957.tb00142.x
Gaster, 1998, The selective 5-HT1B receptor inverse agonist 1′-methyl-5-[[2′-methyl-4′-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo, J Med Chem, 41, 1218, 10.1021/jm970457s
George, 2000, Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties, J Biol Chem, 275, 26128, 10.1074/jbc.M000345200
Gerald, 1995, The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants, EMBO J, 14, 2806, 10.1002/j.1460-2075.1995.tb07280.x
Gershon, 1999, Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel, Aliment Pharmacol Ther, 13, 15, 10.1046/j.1365-2036.1999.00002.x-i2
Glennon, 2000, 2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors, J Med Chem, 43, 1011, 10.1021/jm990550b
Grailhe, 2001, Human 5-HT5 receptors: the 5-HT5A receptor is functional but the 5-HT5B receptor was lost during mammalian evolution, Eur J Pharmacol, 418, 157, 10.1016/S0014-2999(01)00933-5
Green, 1985, The effects of drugs on serotonin-mediated behavioral models, 326
Grimaldi, 1997, Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain, Neuropharmacology, 36, 1079, 10.1016/S0028-3908(97)00099-3
Grimaldi, 1999, 5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety, Neuroscience, 93, 1223, 10.1016/S0306-4522(99)00322-X
Gustafson, 1996, A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain, Br J Pharmacol, 117, 657, 10.1111/j.1476-5381.1996.tb15241.x
Hagan, 2000, Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist, Br J Pharmacol, 130, 539, 10.1038/sj.bjp.0703357
Hamon, 2000, The role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine: current hypotheses, Pathol Biol, 48, 619
Hanna, 2000, Evidence for expression of heteromeric serotonin 5-HT3 receptors in rodents, J Neurochem, 75, 240, 10.1046/j.1471-4159.2000.0750240.x
Hartig, 1992, A subfamily of 5-HT1D receptor genes, Trends Pharmacol Sci, 13, 152, 10.1016/0165-6147(92)90053-9
Hartig, 1996, Alignment of receptor nomenclature with the human genome. Effects on classification of 5-HT1D/5-HT1B receptor subtypes, Trends Pharmacol Sci, 17, 103, 10.1016/0165-6147(96)30002-3
Hedlund, 1999, Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine 7 receptors, Biochem Pharmacol, 58, 1807, 10.1016/S0006-2952(99)00274-9
Heidmann, 1997, Four 5-hydroxytryptamine 7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization, J Neurochem, 68, 1372, 10.1046/j.1471-4159.1997.68041372.x
Heidmann, 1998, Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing, Neuropharmacology, 37, 1621, 10.1016/S0028-3908(98)00070-7
Heisler, 1998, Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice, Proc Natl Acad Sci U S A, 95, 15049, 10.1073/pnas.95.25.15049
Herrick-Davis, 1999, Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction, J Neurochem, 73, 1711, 10.1046/j.1471-4159.1999.731711.x
Hirst, 2000, Characterization of [125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain tissue, Br J Pharmacol, 130, 1597, 10.1038/sj.bjp.0703458
Hope, 1993, Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit, Eur J Pharmacol, Mol Pharmacol Sect, 245, 187, 10.1016/0922-4106(93)90128-V
Hopwood, 2001, Multiple 5-HT1 autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei, Neuropharmacology, 40, 508, 10.1016/S0028-3908(00)00192-1
Hou, 2001, 5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase, Brain Res, 909, 112, 10.1016/S0006-8993(01)02645-2
Hoyer, 1988, Molecular pharmacology and biology of 5-HT1C receptors, Trends Pharmacol Sci, 9, 89, 10.1016/0165-6147(88)90174-5
Hoyer, 1990, 5-HT3, 5-HT4 and 5-HT-M receptors, Neuropsychopharmacology, 3, 371
Hoyer, 1997, 5-HT receptor classification and nomenclature: towards a harmonization with the human genome, Neuropharmacology, 36, 419, 10.1016/S0028-3908(97)00036-1
Hoyer, 1989, Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain, Trends Pharmacol Sci, 10, 130, 10.1016/0165-6147(89)90159-4
Hoyer, 1985, Characterization of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol, Eur J Pharmacol, 118, 1, 10.1016/0014-2999(85)90657-0
Hoyer, 1985, Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin, Eur J Pharmacol, 118, 13, 10.1016/0014-2999(85)90658-2
Hoyer, 1994, International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol Rev, 46, 157
Humphrey, 1993, A new nomenclature for 5-HT receptors, Trends Pharmacol Sci, 14, 233, 10.1016/0165-6147(93)90016-D
Jasper, 1997, Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b), Br J Pharmacol, 122, 126, 10.1038/sj.bjp.0701336
Jerman, 2001, Pharmacological characterisation of human 5-HT2 receptor subtypes, Eur J Pharmacol, 414, 23, 10.1016/S0014-2999(01)00775-0
Johnson, 1997, 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs, NeuroReport, 8, 2237, 10.1097/00001756-199707070-00029
Jorgensen, 1999, Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds, J Neuroendocrinol, 11, 283, 10.1046/j.1365-2826.1999.00328.x
Jorgensen, 2001, Differential effect of serotonin 5-HT1A receptor antagonists on the secretion of corticotropin and prolactin, Neuroendocrinology, 73, 322, 10.1159/000054649
Kalkman, 1995, RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors, Naunyn-Schmiedeberg's Arch Pharmacol, 352, 583, 10.1007/BF00169395
Kaumann, 1994, 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade, Naunyn-Schmiedeberg's Arch Pharmacol, 349, 331, 10.1007/BF00170877
Kawahara, 1994, Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurons, J Physiol (London), 478, 67, 10.1113/jphysiol.1994.sp020230
Kennett, 1994, In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist, Br J Pharmacol, 111, 797, 10.1111/j.1476-5381.1994.tb14808.x
Kennett, 1996, In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties, Br J Pharmacol, 117, 427, 10.1111/j.1476-5381.1996.tb15208.x
Kennett, 1997, BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats, Neuropharmacology, 36, 233, 10.1016/S0028-3908(96)00171-2
Kennett, 1997, SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist, Neuropharmacology, 36, 609, 10.1016/S0028-3908(97)00038-5
Kohen, 1996, Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor, J Neurochem, 66, 47, 10.1046/j.1471-4159.1996.66010047.x
Kursar, 1992, Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus, Mol Pharmacol, 42, 549
Laporte, 1992, Autoradiographic mapping of central 5-HT3 receptors, 157
Larsson, 1990, Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT, Neuropharmacology, 29, 86, 10.1016/0028-3908(90)90047-U
Lee, 2000, Oligomerization of dopamine and serotonin receptors, Neuropsychopharmacology, 23, S32, 10.1016/S0893-133X(00)00155-X
Lee, 2001, Orphan G protein-coupled receptors in the CNS, Curr Opin Pharmacol, 1, 31, 10.1016/S1471-4892(01)00003-0
Lewis, 1960, The inhibition by morphine of the action of smooth muscle stimulants on the guinea-pig intestine, Br J Pharmacol Chemother, 15, 425, 10.1111/j.1476-5381.1960.tb01267.x
Leysen, 1996, Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D-alpha, human 5-hydroxytryptamine1D-beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan, Mol Pharmacol, 50, 1567
Lovell, 2000, A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl) pyrrolidine-1-sulfonyl) phenol (SB-269970), J Med Chem, 43, 342, 10.1021/jm991151j
Lovenberg, 1993, A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms, Neuron, 11, 449, 10.1016/0896-6273(93)90149-L
Lucki, 1992, 5-HT1 receptors and behavior, Neurosci Biobehav Rev, 16, 83, 10.1016/S0149-7634(05)80055-7
Maricq, 1991, Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel, Science, 254, 432, 10.1126/science.1718042
Martin, 1994, Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature, Neuropharmacology, 33, 261, 10.1016/0028-3908(94)90058-2
Martin, 1998, 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential, J Pharmacol Exp Ther, 286, 913
Martin, 1999, Electrophysiological comparison of 5-hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing, J Pharmacol Exp Ther, 288, 820
Massot, 1996, 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors, Mol Pharmacol, 50, 752
Matthes, 1993, Mouse 5-hydroxytryptamine 5A and 5-hydroxytryptamine 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization, Mol Pharmacol, 43, 313
Mayorga, 2001, Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice, J Pharmacol Exp Ther, 298, 1101
McCall, 1994, Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine 1A agonist, J Pharmacol Exp Ther, 271, 875
McKune, 2001, Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling, J Pharmacol Exp Ther, 297, 88
Mehta, 2001, Increased mCPP-induced oral dyskinesia after lesion of serotonergic neurons, Pharmacol, Biochem Behav, 68, 347, 10.1016/S0091-3057(00)00476-7
Meneses, 2001, Effects of the 5-ht6 receptor antagonist Ro 04-6790 on learning consolidation, Behav Brain Res, 118, 107, 10.1016/S0166-4328(00)00316-8
Mialet, 2000, Isolation of the serotoninergic 5-HT4e receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines, Br J Pharmacol, 129, 771, 10.1038/sj.bjp.0703101
Mialet, 2000, Pharmacological characterization of the human 5-HT4d receptor splice variant stably expressed in Chinese hamster ovary cells, Br J Pharmacol, 131, 827, 10.1038/sj.bjp.0703641
Middlemiss, 1990, The 5-HT1B receptors, Ann NY Acad Sci, 600, 132, 10.1111/j.1749-6632.1990.tb16878.x
Middlemiss, 1999, SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor, Eur J Pharmacol, 375, 359, 10.1016/S0014-2999(99)00262-9
Millan, 1997, Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors, Eur J Pharmacol, 321, R11, 10.1016/S0014-2999(97)00050-2
Millan, 1993, Induction of hypothermia as a model of 5-hydroxytryptamine 1A receptor-mediated activity in the rat A pharmacological characterization of the actions of novel agonists and antagonists, J Pharmacol Exp Ther, 264, 1364
Millan, 1997, 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists, Eur J Pharmacol, 325, 9, 10.1016/S0014-2999(97)89962-1
Millan, 1998, Serotonin (5-HT) 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo, Neuropharmacology, 37, 953, 10.1016/S0028-3908(98)00078-1
Miller, 1992, Quantitative autoradiography of 5-CT-sensitive (5-HT1D) and 5-CT-insensitive (5-HT1E) serotonin receptors in human brain, Neurosci Lett, 136, 223, 10.1016/0304-3940(92)90054-B
Miquel, 1995, Developmental changes in the differential expression of two serotonin 5-HT3 receptor splice variants in the rat, J Neurochem, 65, 475, 10.1046/j.1471-4159.1995.65020475.x
Mullins, 1999, Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus, Neuropsychopharmacology, 21, 352, 10.1016/S0893-133X(99)00041-X
Newman-Tancredi, 1998, Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPγS binding study, Eur J Pharmacol, 355, 245, 10.1016/S0014-2999(98)00483-X
Nicholson, 2001, Anaesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain, Anaesthesiology, 94, 120, 10.1097/00000542-200101000-00022
Niswender, 1999, RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity, J Biol Chem, 274, 9472, 10.1074/jbc.274.14.9472
Niswender, 2001, RNA editing of the human serotonin 5-HT2C receptor alterations in suicide and implications for serotonergic pharmacotherapy, Neuropsychopharmacology, 24, 478, 10.1016/S0893-133X(00)00223-2
Norman, 2000, Tegaserod, Novartis AG Current Opinion in Central and Phiphereral Nervous System Investigational Drugs, 2, 344
Ohashi, 2001, Effects of 5-HT-moduline, a novel endogenous peptide, on serotonin release in the prefrontal cortex of freely moving rats, Biog Amines, 16, 101
Ohmori, 2001, Novel polymorphism in the 5′-upstream region of the human 5-HT6 receptor gene and schizophrenia, Neurosci Lett, 310, 17, 10.1016/S0304-3940(01)02075-4
Parker, 1996, Allosteric modulation of 5-HT3 receptor: focus on alcohols and anaesthetic agents, Trends Pharmacol Sci, 17, 95, 10.1016/0165-6147(96)10003-1
Parks, 1998, Increased anxiety of mice lacking the serotonin 1A receptor, Proc Natl Acad Sci U S A, 95, 10734, 10.1073/pnas.95.18.10734
Peroutka, 1979, Multiple serotonin receptors. Differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol, Mol Pharmacol, 16, 687
Phebus, 1997, Characterization of LY 344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine, Life Sci, 61, 2117, 10.1016/S0024-3205(97)00885-0
Pineyro, 1996, Autoregulatory properties of dorsal raphé 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain, Synapse (N.Y.), 22, 54, 10.1002/(SICI)1098-2396(199601)22:1<54::AID-SYN6>3.0.CO;2-H
Price, 1997, SB-216641 and BRL-15572: compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors, Naunyn-Schmiedeberg's Arch Pharmacol, 356, 312, 10.1007/PL00005056
Raap, 1999, Selective serotonin reuptake inhibitors and neuroendocrine function, Life Sci, 65, 1217, 10.1016/S0024-3205(99)00169-1
Rahme, 1999, Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation, Circulation, 100, 2010, 10.1161/01.CIR.100.19.2010
Ramboz, 1995, 5-HT1B receptor knock out—behavioral consequences, Behav Brain Res, 73, 305, 10.1016/0166-4328(96)00119-2
Reynolds, 1995, 5-Hydroxytryptamine (5-HT) 4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases, Br J Pharmacol, 114, 993, 10.1111/j.1476-5381.1995.tb13303.x
Risinger, 1999, Oral operant ethanol self-administration in 5-HT1b knockout mice, Behav Brain Res, 102, 211, 10.1016/S0166-4328(99)00012-1
Roberts, 2001, Interaction of serotonin autoreceptor antagonists in the rat dorsal raphe nucleus: an in vitro fast cyclic voltammetry study, Neurosci Lett, 300, 45, 10.1016/S0304-3940(01)01551-8
Roberts, 1997, Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea pig, Neuropharmacology, 36, 549, 10.1016/S0028-3908(97)00026-9
Roberts, 2000, The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig, Naunyn-Schmiedeberg's Arch Pharmacol, 362, 177, 10.1007/s002100000276
Roberts, 2001, The effect of SB-269970, a 5-HT7 receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies, Br J Pharmacol, 132, 1574, 10.1038/sj.bjp.0703979
Ross, 1999, Robalzotan (NAD-299), a novel selective 5-HT1A receptor antagonist, CNS Drug Rev, 5, 213, 10.1111/j.1527-3458.1999.tb00101.x
Roth, 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors, J Pharmacol Exp Ther, 268, 1403
Rothman, 2000, Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications, Circulation, 102, 2836, 10.1161/01.CIR.102.23.2836
Routledge, 2000, Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist, Br J Pharmacol, 130, 1606, 10.1038/sj.bjp.0703457
Ruat, 1993, Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation, Proc Nat Acad Sci U S A, 90, 8547, 10.1073/pnas.90.18.8547
Saudou, 1994, Enhanced aggressive behavior in mice lacking 5-HT1B receptor, Science (Washington, D. C.), 265, 1875, 10.1126/science.8091214
Schanen, 1996, Assignment of the 5-hydroxytryptamine (serotonin) receptor 5A gene (HTR5A) to human chromosome band 7q361, Cytogenet Cell Genet, 72, 187, 10.1159/000134184
Schlicker, 1997, Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors, Naunyn-Schmiedeberg's Arch Pharmacol, 356, 321, 10.1007/PL00005057
Schreiber, 1995, (1-(2,5-Dimethoxy-4-iodophenyl) -2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists, J Pharmacol Exp Ther, 273, 101
Sebben, 1994, 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurons in culture, NeuroReport, 5, 2553, 10.1097/00001756-199412000-00037
Selkirk, 1998, SB-224289: a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity, Br J Pharmacol, 125, 202, 10.1038/sj.bjp.0702059
Shen, 1993, Molecular cloning and expression of a 5-hydroxytryptamine 7 serotonin receptor subtype, J Biol Chem, 268, 18200, 10.1016/S0021-9258(17)46830-X
Sibella-Arguelles, 2001, The proliferation of human T lymphoblastic cells induced by 5-HT1B receptors activation is regulated by 5-HT-moduline, C R Acad Sci, Ser III, 324, 365, 10.1016/S0764-4469(00)01300-7
Simansky, 1998, Serotonin and the structure of satiation, 217
Sleight, 1995, Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment, Mol Pharmacol, 47, 99
Sleight, 1998, Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-ht6 receptors, Br J Pharmacol, 124, 556, 10.1038/sj.bjp.0701851
Thomas, 1997, Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide, Proc Nat Acad Sci U S A, 94, 14115, 10.1073/pnas.94.25.14115
Thomas, 1998, Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB 258719, Br J Pharmacol, 124, 1300, 10.1038/sj.bjp.0701946
Thomas, 1998, Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling, Ann NY Acad Sci, 861, 183, 10.1111/j.1749-6632.1998.tb10190.x
Thomas, 1999, The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus, J Neurochem, 72, 2370, 10.1046/j.1471-4159.1999.0722370.x
Thomas, 2000, [3H]-SB-269970-A selective antagonist radioligand for 5-HT(7) receptors, Br J Pharmacol, 130, 409, 10.1038/sj.bjp.0703318
To, 1995, Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain, Br J Pharmacol, 115, 107, 10.1111/j.1476-5381.1995.tb16327.x
Trevethick, 1986, 5-Carboxamido-tryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava, Life Sci, 38, 1521, 10.1016/0024-3205(86)90566-7
Tricklebank, 1985, The behavioral response to 5-HT receptor agonists and subtypes of the central 5-HT receptor, Trends Pharmacol Sci, 6, 403, 10.1016/0165-6147(85)90191-9
Tunnicliff, 1991, Molecular basis of buspirone's anxiolytic action, Pharmacol Toxicol, 69, 149, 10.1111/j.1600-0773.1991.tb01289.x
Ullmer, 1995, Expression of serotonin receptor mRNAs in blood vessels, FEBS Lett, 370, 215, 10.1016/0014-5793(95)00828-W
Ullmer, 1996, 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells, Br J Pharmacol, 117, 1081, 10.1111/j.1476-5381.1996.tb16700.x
Van de Kar, 2001, 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells, J Neurosci, 21, 3572, 10.1523/JNEUROSCI.21-10-03572.2001
Van Den Wyngaert, 1997, Cloning and expression of a human serotonin 5-HT4 receptor cDNA, J Neurochem, 69, 1810, 10.1046/j.1471-4159.1997.69051810.x
Van Hooft, 2000, 5-HT3 receptors and neurotransmitter release in the CNS: a nerve ending story?, Trends Neurosci, 23, 605, 10.1016/S0166-2236(00)01662-3
Vickers, 2001, Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors, Neuropharmacology, 41, 200, 10.1016/S0028-3908(01)00063-6
Vollenweider, 1998, Psilosybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action, NeuroReport, 9, 3897, 10.1097/00001756-199812010-00024
Waeber, 1995, [3H]Sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study, Naunyn-Schmiedeberg's Arch Pharmacol, 352, 263, 10.1007/BF00168556
Watson, 2001, SB-272183, a selective 5-HT1A, 5-HT1B and 5-HT1D receptor antagonist in native tissue, Br J Pharmacol, 133, 797, 10.1038/sj.bjp.0704133
Weiss, 1995, Assignment of a human homolog of the mouse Htr3 receptor gene to chromosome 11q23.1–q23.2, Genomics, 29, 304, 10.1006/geno.1995.1254
Wilkinson, 1991, Serotonin and animal behavior, Recept Biochem Methodol, 15, 147
Wong, 1996, Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders, Behav Brain Res, 73, 249, 10.1016/0166-4328(96)00106-4
Woolley, 2001, A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze, Neuropharmacology, 41, 210, 10.1016/S0028-3908(01)00056-9
Xie, 1999, Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed, FEBS Lett, 456, 63, 10.1016/S0014-5793(99)00918-7
Yau, 2001, Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus, Neurosci Lett, 309, 141, 10.1016/S0304-3940(01)02054-7